Publications by authors named "ZhiShang Zhang"

Autoantibodies hold promise for diagnosing lung cancer. However, their effectiveness in early-stage detection needs improvement. We investigated novel IgG and IgM autoantibodies for detection of early-stage lung adenocarcinoma (Early-LUAD) across three independent cohorts of 1246 individuals.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) is a malignant neoplasm that typically manifests with subtle clinical manifestations in its early stages and frequently eludes diagnosis until the advanced phases of the disease. The limited therapeutic options available for PDAC significantly contribute to its high mortality rate, highlighting the urgent need for novel biomarkers capable of effectively identifying early clinical manifestations and facilitating precise diagnosis. The pivotal role of cellular exosomes in both the pathogenesis and therapeutic interventions for PDAC has been underscored.

View Article and Find Full Text PDF

Objective: This study aimed to investigate the impact of lifelong exercise, including both moderate-intensity continuous training and high-intensity interval training, on blood lipid levels and mental behaviour in naturally ageing mice to identify effective exercise strategies for ageing-related health issues.

Methods: Six-week-old male BALB/c mice were randomly assigned to one of four groups: young control (YC), natural ageing control (OC), lifelong moderate-intensity continuous exercise (EM), and lifelong high-intensity interval exercise (EH) groups. The EM group was trained at a speed corresponding to 70 % of the maximum running speed, while the EH group was trained at a running speed alternating between 50 % of the maximum running speed, 70 % of the maximum running speed, and 90 % of the maximum running speed.

View Article and Find Full Text PDF

The design of the dinuclear Ru(II) complex () with strong near-infrared (NIR) absorption properties has been reported for efficient anticancer phototherapy. Under 700 nm LED light excitation, exhibited remarkable synergistic type I/II photosensitization ability and photocatalytic activity toward intracellular biomolecules. showed impressive 700 nm light-triggered anticancer activity under normoxia and hypoxia compared with the clinically used photosensitizer Chlorin e6.

View Article and Find Full Text PDF
Article Synopsis
  • Chemoimmunotherapy is a common treatment for advanced non-small cell lung cancer (aNSCLC), but drug resistance limits its effectiveness, creating a need for reliable biomarkers to predict patient responses.
  • Researchers conducted a three-phase study to identify and validate specific autoantibodies (AAbs) from 528 plasma samples of aNSCLC patients before and after treatment, using various microarray techniques and statistical analyses.
  • They discovered two AAbs (MAX and DHX29) as pre-treatment biomarkers and two others (MAX and TAPBP) as predictive markers during treatment, with all showing significant correlations to patient outcomes like response rates and progression-free survival.
View Article and Find Full Text PDF

Background: Anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs) has demonstrated remarkable therapeutic effects in ALK-positive non-small cell lung cancer (NSCLC) patients. Identifying prognostic biomarkers can enhance the clinical efficacy of relapsed or refractory patients.

Methods: We profiled 737 plasma proteins from 159 pre-treatment and on-treatment plasma samples of 63 ALK-positive NSCLC patients using data-independent acquisition-mass spectrometry (DIA-MS).

View Article and Find Full Text PDF

The response rate of anti-PD1 therapy is limited, and the influence of anti-PD1 therapy on cancer patients is unclear. To address these challenges, we conducted a longitudinal analysis of plasma proteomic changes with anti-PD1 therapy in non-small cell lung cancer (NSCLC), alveolar soft part sarcoma (ASPS), and lymphoma patients. We included 339 plasma samples before and after anti-PD1 therapy from 193 patients with NSCLC, ASPS, or lymphoma.

View Article and Find Full Text PDF

Due to the antibiotics abuse, bacterial infection has become one of the leading causes of human death worldwide. Novel selective antimicrobial agents are urgently needed, with the hope of maintaining the balance of the microbial environment. Photo-activated chemotherapeutics have shown great potential to eliminate bacteria with appealing spatiotemporal selectivity.

View Article and Find Full Text PDF

Background: R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) is a standard first-line treatment for diffuse large B-cell lymphoma (DLBCL). However, 20%-40% of patients survive less than 5 years. Novel prognostic biomarkers remain in demand.

View Article and Find Full Text PDF

Background: Research on immunogenicity after 3 SARS-CoV-2 vaccine in elder hepatocellular carcinoma (HCC) was limited. This study aimed to investigate the efficacy and influencing factors of inactivated SARS-CoV-2 vaccine in elder HCC.

Research Design And Methods: We assessed total antibodies, anti-RBD IgG, and neutralizing antibodies (NAb) toward SARS-CoV-2 wild type (WT) as well as BA.

View Article and Find Full Text PDF

The challenge of antibiotic resistance worldwide has brought an urgent need to explore novel drugs for bacterial infections. Antimicrobial photodynamic therapy has been proven to be a potential antimicrobial modality but is limited by biofilms. In this study, we synthesized three cationic photosensitizers with strong photoinduced antimicrobial and antibiofilm activities toward gram-positive Staphylococcus aureus.

View Article and Find Full Text PDF

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease, although disease stratification using in-depth plasma proteomics has not been performed to date. By measuring more than 1000 proteins in the plasma of 147 DLBCL patients using data-independent acquisition mass spectrometry and antibody array, DLBCL patients were classified into four proteomic subtypes (PS-I-IV). Patients with the PS-IV subtype and worst prognosis had increased levels of proteins involved in inflammation, including a high expression of metalloproteinase inhibitor-1 (TIMP-1) that was associated with poor survival across two validation cohorts (n = 180).

View Article and Find Full Text PDF

COVID-19 inactivated vaccine-induced humoral responses in patients with lung cancer (LCs) to SARS-CoV-2 wild-type (WT) strain and variants BA.4/5 after the primary 2-dose and booster vaccination remained unknown. We conducted a cross-sectional study in 260 LCs, 140 healthy controls (HC) and additional 40 LCs with serial samples by detecting total antibodies, IgG anti-RBD and neutralizing antibodies (NAb) toward WT and BA.

View Article and Find Full Text PDF

Background: Early diagnosis is critical to lung adenocarcinoma patients' survival but faces inadequacies in convenient early detection.

Methods: We applied a comprehensive microarray of 130,000 peptides to detect "autoantibody signature" that is autoantibodies binding to mimotopes for early detection of stage 0-I LUAD. Plasma samples were collected from 147 early-stage lung adenocarcinoma (Early-LUAD), 108 benign lung disease (BLD), and 122 normal healthy controls (NHC).

View Article and Find Full Text PDF

Photodynamic therapy (PDT) for cancer treatment has garnered tremendous attention with its promising non-invasiveness, low side effects, and spatiotemporal selectivity. However, the hypoxic microenvironment in solid tumours remains a serious resistant factor to reducing the effects of PDT. Endoperoxides are successfully utilized as the chemical storage or supplier of singlet oxygen ( O ), the active substance for PDT in materials and other domains.

View Article and Find Full Text PDF

Objective: To investigate the histomorphological characteristics of the gastric mucosa and the prognosis in patients with infection.

Methods: Progressive damage to the gastric mucosa was examined by immunohistochemistry in 2294 patients with infection and follow-up information was analyzed.

Results: initially colonized the mucus layer covered by the gastric mucosa epithelium, then selectively adhered to and destroyed the surface mucus cells causing intra-gastric and extra-gastric lesions.

View Article and Find Full Text PDF
Article Synopsis
  • Toripalimab is a monoclonal antibody targeting programmed death receptor-1, showing promise in treating various cancers, but there's currently limited methodology for its quantification, mainly relying on electrochemiluminescence immunoassay (ECLIA).
  • Researchers developed a sensitive ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method, which involved a detailed five-step sample preparation process to accurately measure toripalimab levels in plasma.
  • The study, which analyzed 77 samples from patients in a phase I trial, found that UPLC-MS/MS reported significantly higher toripalimab levels compared to ECLIA, indicating that UPLC-MS/MS could be a valuable tool for quant
View Article and Find Full Text PDF

Background: Antibodies targeting programmed cell death-1(PD1) and its ligand (PDL1) have revolutionized cancer therapy. However, little is known about the preexisted anti-PD1/PDL1 autoantibodies (AAbs) distribution in multiple cancer types, nor is their potential biomarker role for anti-PD1 therapy.

Method: Plasma anti-PD1/PDL1 AAb IgG and subclasses (IgG1-4) were detected by enzyme-linked immune sorbent assay (ELISA) in 190 cancer patients, covering 10 cancer types (lung, breast, esophageal, colorectal, liver, prostatic, cervical, ovarian, gastric cancers and lymphoma), the comprehensive correlation of AAbs with multiple clinical parameters was analyzed.

View Article and Find Full Text PDF

Background: This study aimed to recognize the hub genes associated with prognosis in follicular lymphoma (FL) treated with first-line rituximab combined with chemotherapy.

Method: RNA sequencing data of dataset GSE65135 (n = 24) were included in differentially expressed genes (DEGs) analysis. Weighted gene co-expression network analysis (WGCNA) was applied for exploring the coexpression network and identifying hub genes.

View Article and Find Full Text PDF

Background: Chemotherapy plus granulocyte colony-stimulating factor (GCSF) regimen is one of the available approaches to mobilize peripheral blood progenitor cells (PBPCs). It causes thrombocytopenia and delays leukapheresis. This study aimed to evaluate the role of recombinant human thrombopoietin (rhTPO) before mobilization chemotherapy in facilitating leukapheresis in patients with lymphoma.

View Article and Find Full Text PDF

There is a discrepancy in the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment for advanced lung adenocarcinoma (LUAD) patients with sensitizing mutations (). Molecular markers other than remain to be investigated to better predict EGFR-TKI efficacy. Here, 49 LUAD patients with (19 deletions or 21 L858R mutations) who received the first-generation EGFR-TKI icotinib therapy were included and stratified into 25 good-responders with a progression-free survival (PFS) longer than 11 months and 24 poor-responders with a PFS shorter than 11 months.

View Article and Find Full Text PDF

Objective: To study the clinicopathological features and differential diagnosis of gastrofibromatosis-like undifferentiated carcinoma (GFLUC).

Methods: Three patients with GFLUC underwent histological and immunophenotypic analyses and fluorescence hybridization to detect human epidermal growth factor receptor () gene amplification.

Results: Among the three patients (2 male [36 and 44 years old], 1 female [58 years old]), two had lesions in the gastric body and one had lesions in the gastric antrum.

View Article and Find Full Text PDF

: Programmed cell death protein 1 (PD1) inhibitors have revolutionized cancer therapy, yet many patients fail to respond. Thus, the identification of accurate predictive biomarkers of therapy response will improve the clinical benefit of anti-PD1 therapy. : We assessed the baseline serological autoantibody (AAb) profile against ~2300 proteins in 10 samples and ~4600 proteins in 35 samples with alveolar soft part sarcoma (ASPS), non-small-cell lung cancer (NSCLC) and lymphoma using Nucleic Acid Programmable Protein Arrays (NAPPA).

View Article and Find Full Text PDF
Article Synopsis
  • This phase I study evaluates toripalimab, a monoclonal antibody targeting the PD-1 receptor, for safety and effectiveness in Chinese patients with advanced cancer not responding to standard treatments.
  • A total of 33 patients participated, with diverse cancers and a history of multiple treatments, showing that toripalimab had manageable side effects and prompted some positive responses, particularly in lymphoma cases.
  • The results indicated a significant objective response rate, especially in lymphoma patients, and overall a well-tolerated treatment with potential long-lasting benefits, particularly for patients with alveolar soft part sarcoma (ASPS).
View Article and Find Full Text PDF

This paper presents a feature classification method based on vision sensor in dynamic environment. Aiming at the detected targets, a double-projection error based on orb and surf is proposed, which combines texture constraints and region constraints to achieve accurate feature classification in four different environments. For dynamic targets with different velocities, the proposed classification framework can effectively reduce the impact of large-area moving targets.

View Article and Find Full Text PDF